- Home
- THRD vs FMNB Comparison
THRD vs FMNB Comparison
Compare THRD & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- FMNB
- Stock Information
- Founded
- THRD 2019
- FMNB 1887
- Country
- THRD United States
- FMNB United States
- Employees
- THRD N/A
- FMNB N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- FMNB Major Banks
- Sector
- THRD Health Care
- FMNB Finance
- Exchange
- THRD Nasdaq
- FMNB Nasdaq
- Market Cap
- THRD 512.9M
- FMNB 519.3M
- IPO Year
- THRD 2022
- FMNB N/A
- Fundamental
- Price
- THRD $13.93
- FMNB $15.29
- Analyst Decision
- THRD Strong Buy
- FMNB Hold
- Analyst Count
- THRD 3
- FMNB 4
- Target Price
- THRD $20.33
- FMNB $15.25
- AVG Volume (30 Days)
- THRD 184.1K
- FMNB 89.4K
- Earning Date
- THRD 11-07-2024
- FMNB 10-23-2024
- Dividend Yield
- THRD N/A
- FMNB 4.38%
- EPS Growth
- THRD N/A
- FMNB N/A
- EPS
- THRD N/A
- FMNB 1.23
- Revenue
- THRD N/A
- FMNB $162,960,000.00
- Revenue This Year
- THRD N/A
- FMNB N/A
- Revenue Next Year
- THRD N/A
- FMNB $5.71
- P/E Ratio
- THRD N/A
- FMNB $12.97
- Revenue Growth
- THRD N/A
- FMNB N/A
- 52 Week Low
- THRD $5.82
- FMNB $11.55
- 52 Week High
- THRD $16.94
- FMNB $16.32
- Technical
- Relative Strength Index (RSI)
- THRD 54.76
- FMNB 59.26
- Support Level
- THRD $11.69
- FMNB $13.70
- Resistance Level
- THRD $14.64
- FMNB $16.02
- Average True Range (ATR)
- THRD 0.99
- FMNB 0.48
- MACD
- THRD -0.04
- FMNB 0.15
- Stochastic Oscillator
- THRD 67.67
- FMNB 72.46
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of company's revenue is derived from the bank segment.